Reassessing pravastatin in adult autosomal dominant polycystic kidney disease and potential subgroup benefits

Scritto il 21/02/2026
da Youyi Lu

No abstract

Kidney Int. 2026 Mar;109(3):605. doi: 10.1016/j.kint.2025.12.007.

NO ABSTRACT

PMID:41722945 | DOI:10.1016/j.kint.2025.12.007